Banner Publications MH200828 N141

Publications

Results found: 213

Showing results: 1 - 50

Nature medicine

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.

01-12-2020
Key
Nature

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.

01-08-2019
Key
Clinical cancer research : an official journal of the American Association for Cancer Research

PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC.

14-11-2022
Med (New York, N.Y.)

Next generation T cell therapies for solid cancers.

14-10-2022
Cancer discovery

When Cancer Cells Become the Enablers of an Antitumor Immune Response.

05-10-2022
Immuno-oncology technology

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial.

01-09-2022
Nature immunology

Author Correction: Replicative history marks transcriptional and functional disparity in the CD8+ T cell memory pool.

01-07-2022
Nature reviews. Immunology

The precursors of CD8+ tissue resident memory T cells: from lymphoid organs to infected tissues.

01-05-2022
Nature immunology

Replicative history marks transcriptional and functional disparity in the CD8+ T cell memory pool.

01-05-2022
Nature biotechnology

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.

01-04-2022
Oncoimmunology

QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment.

22-03-2022
Current opinion in immunology

Safety switches for adoptive cell therapy.

01-02-2022
Science (New York, N.Y.)

Tertiary lymphoid structures in cancer.

07-01-2022
Nature communications

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.

22-12-2021
Science (New York, N.Y.)

An atlas of intratumoral T cells.

17-12-2021
Cell reports

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells.

16-11-2021
Nature chemical biology

Single-cell analysis of regions of interest (SCARI) using a photosensitive tag.

01-11-2021
Proceedings of the National Academy of Sciences of the United States of America

Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.

26-10-2021
Human gene therapy

Multimodular Optimization of Chemically Regulated T Cell Switches Demonstrates Flexible and Interchangeable Nature of Immune Cell Signaling Domains.

01-10-2021
Cancer discovery

Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.

01-10-2021
Cancer immunology research

CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function.

01-09-2021
Cold Spring Harbor perspectives in biology

Formation of Tissue-Resident CD8+ T-Cell Memory.

02-08-2021
Journal for immunotherapy of cancer

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.

01-08-2021
Nature medicine

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer.

01-07-2021
Nature communications

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features.

10-05-2021
Current opinion in immunology

Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines.

01-04-2021
Nature protocols

Labeling and tracking of immune cells in ex vivo human skin.

01-02-2021
Nature medicine

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.

01-02-2021
Journal for immunotherapy of cancer

Comprehensive analysis of cutaneous and uveal melanoma liver metastases.

01-12-2020
Cell

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

29-10-2020
The Journal of experimental medicine

A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool.

05-10-2020
Journal for immunotherapy of cancer

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.

01-08-2020
Nature cancer

Publisher Correction: Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ.

01-07-2020
Nature immunology

Author Correction: Tissue patrol by resident memory CD8+ T cells in human skin.

01-06-2020
Communications biology

A mouse model that is immunologically tolerant to reporter and modifier proteins.

29-05-2020
Immunity

The CD47-SIRPα Immune Checkpoint.

19-05-2020
Cancer immunology research

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.

01-05-2020
Nature medicine

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

01-04-2020
Nature reviews. Cancer

CD8+ T cell states in human cancer: insights from single-cell analysis.

01-04-2020
Proceedings of the National Academy of Sciences of the United States of America

CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

24-03-2020
Nature cancer

Long-distance modulation of bystander tumor cells by CD8+ T cell-secreted IFNγ.

01-03-2020
Immunity

Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.

18-02-2020
Nature protocols

Tumor organoid-T-cell coculture systems.

01-01-2020
Nature

B cells and tertiary lymphoid structures promote immunotherapy response.

01-01-2020
Nature communications

Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

26-11-2019
Nature reviews. Immunology

Defining 'T cell exhaustion'.

01-11-2019
Nature communications

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection.

01-11-2019
Cell

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.

25-07-2019
The Lancet. Oncology

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

01-07-2019
Nature medicine

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

01-07-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.